Cardiovascular disease

Also called CVD

There are 13,759 papers on cardiovascular disease in aging research: 723 trials and 7,518 observational studies in people, 144 in animals, 9 in cells, 4,777 reviews. The newest story, Nov 19, 2026: “Liver risk scores linked to dementia, cancer and death”.

Disease

13,759 papers study it9,432 more mention it4,612 findings

MeSH

1,931 new papers in 30 daysSee all 23,192 papers on cardiovascular disease

“a primary cardiovascular event had occurred in 297 participants (10.9 events per 1000 person-years) in the atorvastatin group and in 412 participants (15.5 events per 1000 person-years) in the placebo group”
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older AdultsThe New England journal of medicine2026doi:10.1056/nejmoa2607314
  • Human trial723
  • Humans7,518
  • Animals139
  • Model organisms5
  • Cells9
  • In silico394

Interventions

25

Mediterranean diet

downin humans2downin reviews1

3 studies
  1. Mediterranean diet is linked with less cardiovascular disease in humans.

    “adherence to the MD acts as a protective factor against both oral and systemic diseases.”

    Humans

    Mediterranean diet and its relationship with oral pathology

    Acta odontologica Scandinavica

  2. Mediterranean diet protects against cardiovascular disease in humans.

    “consistently shown protective effects against cardiovascular disease, type 2 diabetes, various cancers, and cognitive decline”

    Review

    The Mediterranean pyramid: 30 years later, still relevant

    European journal of nutrition

  3. Mediterranean diet protects against cardiovascular disease.

    “The Mediterranean Diet and related trials showed that their beneficial effects on cardiovascular disorders”

    Review

    Low-Grade Chronic Inflammation and Atherosclerotic Cardiovascular Risk: The Beneficial Role of Specific Nutritional Approaches

    Nutrients

More on Mediterranean diet

Physical activity

downin humans2OR 0.56

2 studies
  1. Physical activity is linked with less cardiovascular disease in humans (adults with diabetes) (adjusted OR 0.56; 95% CI 0.33–0.95).

    “Regular physical activity was protective (adjusted OR 0.56; 95% CI 0.33–0.95).”

    Humansadults with diabetes

    Prevalence of High Predicted 10‑Year Cardiovascular Disease Risk Among Hypertensive Asymptomatic Diabetic Outpatients in Dar es Salaam, Tanzania Using a Locally Adapted Framingham Risk Score

    Tanzania Medical Journal

  2. Physical activity is linked with less cardiovascular disease in humans (comparing 95th to 5th percentile of total activity) (TR=1.56, 95%CI:1.28-1.82).

    “increased protective association of total physical activity after SIMEX correction (Time Ratio [TR]=1.56, 95%CI:1.28-1.82 vs. TR=1.38, 95%CI:1.24-1.54”

    Humanscomparing 95th to 5th percentile of total activity

    Addressing Measurement Error of Machine-Learned Physical Activity in Nonlinear Dose-Response Survival Analysis: Development and Evaluation of Accelerated Failure Time, Spline, and Simulation-Extrapolation Method

    medRxivPreprint

More on Physical activity

SGLT2 inhibitors

downin reviews2

2 studies
  1. SGLT2 inhibitors protect against cardiovascular disease.

    “Meta-analyses and large cohort studies in recent years confirm their cardio- and renoprotective efficacy”

    Review

    Modern glucose-lowering drugs SGLT2 inhibitors and GLP-1 agonists in the prevention of cardiovascular disease and dementia in patients with diabetes and metabolic disorders

    Terapevt (General Physician)

  2. SGLT2 inhibitors protect against cardiovascular disease.

    “confer cardiovascular, renal, and hepatic benefits that extend well beyond glycemic control”

    Review

    Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception

    Cardiovascular diabetology

More on SGLT2 inhibitors

Exercise

downin humans1downin reviews1

2 studies
  1. Exercise decreases cardiovascular disease.

    “the ameliorative effect of exercise on cardiovascular diseases is related to the regulation of the cGAS-STING signaling pathway”

    Reviewmediated through regulation of the cGAS-STING signaling pathway, as reported in prior studies

    Mechanism of Association Between Abnormity of Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase-Stimulator of Interferon Gene Pathway and Cardiovascular Diseases and the Exercise Regulation:A Review

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

  2. Exercise protects against cardiovascular disease in humans.

    “how exercise training reshapes lncRNA transcriptomic landscape to exert cardioprotective effects”

    Review

    Exercise-Induced Regulation of LncRNAs: Mechanistic Insights and Clinical Translation in Cardiovascular Health

    Journal of cardiovascular translational research

More on Exercise

Bilateral salpingo-oophorectomy

no changein humans1HR 0.99

1 study
  1. Bilateral salpingo-oophorectomy was not clearly linked with cardiovascular disease in humans (Non-malignant hysterectomy; compared with ovarian conservation) (HR 0.99, 95% CI 0.88-1.12).

    “BSO was not associated with cardiovascular disease (50-54y: HR 0.99, 95% CI 0.88-1.12, p=0.85; ≥55y: HR 0.96, 95% CI 0.86-1.08, p=0.50)”

    HumansNon-malignant hysterectomy; compared with ovarian conservationfemales

    Ovary removal at 50–70 with noncancer hysterectomy not tied to 3 risks

    Journal of minimally invasive gynecology

More on Bilateral salpingo-oophorectomy

Incretin mimetics

downin humans1

1 study
  1. Incretin mimetics protect against cardiovascular disease in older patients with type 2 diabetes.

    “Incretin mimetics also offer cardiovascular benefits in older patients with type 2 diabetes (T2DM) with potential benefits of replacing other anti-diabetes agents and reducing polypharmacy.”

    Reviewin older patients with type 2 diabetes

    Newer Diabetes Medications in Older Adults with or At Risk for Cardiovascular Disease

    Current geriatrics reports

More on Incretin mimetics

Retinal ai-guided pre-screening triage strategy

no changein humans1

1 study
  1. Retinal ai-guided pre-screening triage strategy was not clearly linked with cardiovascular disease in humans (non-inferiority compared to standard safe cohort) (hazard ratio 1.08; 95% confidence interval 0.95-1.21).

    “The Cox proportional hazards model confirmed no significant difference in CVD risk between the Retinal AI-guided and standard safe cohorts (hazard ratio 1.08; 95% confidence interval 0.95-1.21; p=0.245).”

    Humansnon-inferiority compared to standard safe cohortmedian 10.0 yearsn = 40,850

    Integrating a Retinal AI score into the NHS systemic cardiovascular prevention pathway: a validation study based on NICE Guidelines

    ESC Congress 2026 abstract

More on Retinal ai-guided pre-screening triage strategy

Sugar and salt tax

downin silico1

1 study
  1. Sugar and salt tax decreases cardiovascular disease in silico (UK representative synthetic population).

    “Long-term modelling showed improved health, including reduced cardiovascular disease, and type 2 diabetes for all three tax policies.”

    In silicoUK representative synthetic populationLifetime simulation

    The effect of food taxes in the UK on health and economic outcomes, and equity: a modelling study

    The Lancet. Public health

More on Sugar and salt tax

Smoking

no changein humans1

1 study
  1. Smoking was not clearly linked with cardiovascular disease in humans (Participants with COPD; smokers compared with never smokers).

    “Among men with COPD, smoking exposure confers no added hazard”

    HumansParticipants with COPD; smokers compared with never smokersMedian follow-up of 10 yearsmales

    Lung disease linked to cardiovascular disease in never-smokers

    Chinese medical journal

More on Smoking

Blueberries

no changein humans1

1 study
  1. Blueberries were not clearly linked with cardiovascular disease in humans.

    “similar null findings observed for anthocyanin subclasses and blueberries.”

    Humans28.0 yearsfemalesn = 38,088

    Anthocyanin and Blueberry Intake, Lipids, C-Reactive Protein, and the Risk of Cardiovascular Disease in Women

    Journal of the American Heart Association

More on Blueberries

All 25

Effects

7

Intrinsic capacity

downin humans1

1 study
  1. Cardiovascular disease is linked with lower intrinsic capacity in humans (β = -0.135).

    “followed by cardiovascular diseases (β = -0.135, P < .01).”

    Humans

    Multiple chronic conditions link to lower intrinsic capacity

    Medicine

Non-failing homeostatic LEC state

downin humans1

1 study
  1. Cardiovascular disease is linked with lower non-failing homeostatic LEC state in humans.

    “Cardiovascular diseases showed a distinct trajectory, with depletion of a non-failing homeostatic state and expansion of shared and disease-associated remodeling states.”

    Humansheart

    Physiological Aging and Cardiovascular Disease Distinctly Remodel the Human Cardiac Lymphatic Endothelium

    bioRxivPreprint

Transfer entropy

downin humans1

1 study
  1. Cardiovascular disease is linked with lower transfer entropy in patients with CVD (85.4 ± 0.8 mnats vs 87.9 ± 0.5 mnats (p < 0.001)).

    “Our results indicate a significantly ( p < 0.001 ) lower TE in patients with CVD ( 85.4 ± 0.8 mnats) than that in healthy controls ( 87.9 ± 0.5 mnats)”

    Humansin patients with CVD

    Robust information transfer calculation reveals dynamic networks during sleep arousal

    Frontiers in network physiology

More on Transfer entropy

Depressive symptoms score

upin humans1

1 study
  1. Cardiovascular disease is linked with higher depressive symptoms score in humans (around the time of CVD diagnosis) (pooled β: 0.089 SD [0.060-0.118]).

    “A significant increase in depressive symptoms scores was observed around the time of CVD diagnosis (pooled β: 0.089 SD [0.060-0.118]).”

    Humansaround the time of CVD diagnosisn = 28,704

    Depressive Symptoms Trajectories Across the Transition to Cardiovascular Disease in Middle-Aged and Older Adults: A Multicohort Study

    European journal of preventive cardiology

More on Depressive symptoms score

Cognitive function

mediatesin humans1

1 study
  1. Cardiovascular disease mediates cognitive function in humans (air pollution exposure effect on cognitive aging).

    “Cardio and Cerebro-vascular diseases emerged as a potential key mediator.”

    Reviewair pollution exposure effect on cognitive aging

    Ambient air pollution exposure and cognitive aging, mediators and possible pathways: A systematic review on the epidemiological studies

    Ageing research reviews

Age-standardized cardiovascular disease burden

downin humans1−36%

1 study
  1. Cardiovascular disease is linked with lower age-standardized cardiovascular disease burden in humans (-36.2%).

    “despite 36.2% reduction in age-standardised DALYs.”

    Humans

    Burden of cardiovascular diseases in the Asia-Pacific region from 1990 to 2023, with forecasts to 2050: a secondary analysis of the Global Burden of disease study 2023

    The Lancet regional health. Western Pacific

Quality of life

no changein humans1

1 study
  1. Cardiovascular disease was not clearly linked with quality of life in older adults with cardiovascular disease.

    “neither demographic characteristics nor cardiovascular diagnoses were significantly associated with quality of life.”

    Humansin older adults with cardiovascular diseasen = 100

    Multidimensional Frailty and Resilience in Relation to Quality of Life in Senior Patients with Cardiovascular Disease: An Exploratory Cross-Sectional Pilot Study

    Journal of clinical medicine

Upstream

38

Posttraumatic stress disorder

no changein humans1OR 0.98

1 study
  1. Posttraumatic stress disorder was not clearly linked with cardiovascular disease in humans (Women Veterans; multivariable-adjusted analysis) (OR 0.98, 95% CI 0.82–1.17; p = 0.82).

    “PTSD was not a statistically significant independent predictor of CVD (OR = 0.98, 95% CI = 0.82-1.17, p = 0.82).”

    HumansWomen Veterans; multivariable-adjusted analysisfemalesn = 380

    Posttraumatic Stress Disorder and Cardiovascular Disease Risk in Women Veterans

    AHA Scientific Sessions 2026 abstract

More on Posttraumatic stress disorder

Diabetes mellitus

mediatesin humans1

1 study
  1. Diabetes mellitus is linked with cardiovascular disease in humans (Mediation of the association between eGFRdiff and cardiovascular disease) (48.3% mediated).

    “Diabetes significantly mediated 48.3% of the associations between eGFRdiff and cardiovascular disease.”

    HumansMediation of the association between eGFRdiff and cardiovascular diseaseMedian follow-up of 5.0 yearsBoths

    Discrepancy Between Cystatin C and Creatinine Estimated Glomerular Filtration Rate with Type 2 Diabetes and Progression to Cardiovascular Disease A National Cohort Study

    AHA Scientific Sessions 2026 abstract

More on Diabetes mellitus

metabolic risk pathways

mediatesin humans1

1 study
  1. metabolic risk pathways mediate cardiovascular disease in humans (74.7% mediated; indirect effect β=0.136 (95% CI, 0.112–0.161)).

    “Metabolic pathways collectively mediated 74.7% of the observed association (indirect effect β=0.136; 95% CI, 0.112-0.161).”

    ReviewMediation of the association between metabolic dysfunction-associated steatotic liver disease and cardiovascular disease

    Metabolic and Hepatic Contributions to Cardiovascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analytic Structural Equation Modeling Study

    AHA Scientific Sessions 2026 abstract

Mediterranean Diet Score

no changein humans1HR 0.98

1 study
  1. Mediterranean Diet Score was not clearly linked with cardiovascular disease in humans (20-year follow-up in men: HR 0.98, 95% CI 0.88–1.08).

    “No statistically significant associations were found for CVD or cancer morbidity in either sex”

    Humans10 and 20 years

    Sex-specific associations between Mediterranean Diet Score and long-term risk of mortality, dementia and other chronic diseases. 20-year evidence from a Swedish population study of 70-year old individuals

    The journal of nutrition, health & aging

More on Mediterranean Diet Score

Herpes zoster

no changein humans1HR 1.03

1 study
  1. Herpes zoster was not clearly linked with cardiovascular disease in humans (adults without prior CVD) (HR 1.03, 95% CI 0.90–1.18, p = 0.66).

    “HZ was not significantly associated with increased risk (HR, 1.03; 95% CI, 0.90–1.18; p = 0.66).”

    Humansadults without prior CVDmedian follow-up of 58 monthsn = 94,269

    Herpes zoster and major vascular events in a general population without prior cardiovascular event from Shizuoka Kokuho database

    Scientific reports

More on Herpes zoster

Frailty proteomic signature

mediatesin humans1

1 study
  1. Frailty proteomic signature is linked with cardiovascular disease in humans (mediating the relationship between physical frailty and CVD) (proportion mediated: 49.18% (42.73%–53.40%)).

    “Mediation analyses revealed that the proteomic signature of physical frailty [natural indirect effect: 1.14 (1.12–1.15), proportion mediated: 49.18% (42.73%–53.40%)] and identified hub proteins (e.g., TNF, IL-1β, IL6) partially mediated the relationship between physical frailty and CVD.”

    Humansmediating the relationship between physical frailty and CVDn = 468,801

    Frailty reversal is linked to lower heart disease risk

    NPJ aging

More on Frailty proteomic signature

TRL/Lp(a)-linked chemokine signature

mediatesin humans1

1 study
  1. TRL/Lp(a)-linked chemokine signature is linked with cardiovascular disease in humans (TRL/remnant cholesterol–cardiovascular disease association) (Around 40% of the association, with wide confidence limits).

    “A specific chemokine signature linked to both TRL and Lp(a) accounted for around 40% (with wide confidence limits) of the TRL/remnant cholesterol: cardiovascular disease (CVD) association.”

    HumansTRL/remnant cholesterol–cardiovascular disease associationn = 46,000

    A Chemokine Profile Linked to Both Triglyceride-Rich Lipoproteins and Lipoprotein(a), But Not LDL, Is Associated With Cardiovascular Disease

    JACC. Basic to translational science

More on TRL/Lp(a)-linked chemokine signature

Depression

mediatesin humans1

1 study
  1. Depression is linked with cardiovascular disease in humans (25.33% mediated).

    “Notably, depression mediated 25.33% of the association between DSI and new-onset CVD.”

    HumansMediation of the association between dual sensory impairment and new-onset cardiovascular diseasen = 7,582

    Association between dual sensory impairments and new-onset cardiovascular disease among American middle-aged and older adults: the mediating role of depression

    Preventive medicine reports

More on Depression

Life's Crucial 9

mediatesin humans1

1 study
  1. Life's Crucial 9 is linked with cardiovascular disease in humans (mediates effect of SES shift on incident CVD) (6.33%).

    “Mediation analysis showed that CVH shift significantly mediated the effects of SES shift on incident CVD (6.33%)”

    Humansmediates effect of SES shift on incident CVD9.5 yearsn = 26,721

    Shifts in socioeconomic status alter cardiovascular disease risk and mortality through modulating Life's Crucial 9: a prospective cohort study of UK Biobank participants

    BMJ public health

More on Life's Crucial 9

Mean arterial pressure

mediatesin humans1

1 study
  1. Mean arterial pressure is linked with cardiovascular disease in association between obesity and CVD risk (10.5%–25.6% mediated).

    “mean arterial pressure showed the largest mediating effects (10.5%–25.6%)”

    Humansin association between obesity and CVD risk

    Mediating role of arterial stiffness and hemodynamic load in the association between obesity and cardiovascular disease risk: a prospective cohort study

    Research SquarePreprint

More on Mean arterial pressure

All 38

Associations

548

Triglyceride-glucose index

upin humans12OR 1.27–1.49

12 studies
  1. Triglyceride-glucose index is associated with cardiovascular disease in humans (High TyG only versus low TyG/low SII) (OR 1.49, 95% CI 1.20–1.86).

    “high TyG alone was associated with a 49% higher CVD risk (OR 1.49, 95% CI 1.20–1.86)”

    HumansHigh TyG only versus low TyG/low SIIn = 19,168

    Joint associations of the TyG index and systemic immune-inflammation index with cardiovascular disease: a cohort study

    ESC Congress 2026 abstract

  2. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in adults with CKM stages 0-3 (HR 1.29-1.45).

    “For cumulative dual-high exposure, adjusted Cox HRs for CVD ranged from 1.29 (95% CI 1.09-1.52) to 1.45 (1.20-1.74)”

    Humansin adults with CKM stages 0-35-year follow-upn = 4,420

    Antecedent, landmark, and two-visit cumulative triglyceride-glucose index and non-traditional lipid measures in relation to incident cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome (CKM) stages 0-3: a nationwide prospective cohort study

    Cardiovascular diabetology

  3. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans.

    “there was a significant association of high CHG_TWA/TyG_TWA with the risk of CVD, with these associations being stronger with longer exposure duration to high TyG index and CHG index”

    Humans11.08 yearsn = 46,827

    Comparative associations of cumulative cholesterol-HDL-glucose index and triglyceride-glucose index with risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

    Frontiers in endocrinology

  4. Triglyceride-glucose index is associated with cardiovascular disease in humans (adjusted HR 1.66, 95% CI 1.47–1.88).

    “those concurrently with a higher TyG and comorbidity had the highest risk of CVD (adjusted HR, 1.66; 95% CI, 1.47-1.88)”

    HumansHigher TyG index with comorbidity versus TyG index < 8.59 and no comorbidity; no baseline CVD9-year follow-upn = 9,400

    Triglyceride glucose index, metabolic comorbidity, and cardiovascular disease: a national cohort study

    BMC cardiovascular disorders

  5. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in adults with MASLD, fully adjusted (OR=1.27, P<0.05).

    “TyG (OR=1.27) and TyG-WHtR (OR=1.20) were independently associated with elevated CVD risk after full covariate adjustment”

    Humansin adults with MASLD, fully adjusted

    Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2023

    Therapeutic advances in endocrinology and metabolism

  6. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in people living with HIV-1 infection, highest vs lowest tertile (aHR 3.31, 95% CI 1.10-9.97).

    “PWH in the highest TyG tertile had also higher risk for CVEs compared with those in the lowest tertile (aHR 3.31, 95% CI 1.10-9.97).”

    Humansin people living with HIV-1 infection, highest vs lowest tertilemedian follow-up of 14.2 yearsn = 477

    The Triglyceride-Glucose (TyG) Index and Incident Diabetes and Cardiovascular Events in People Living With HIV-1 Infection. A 14-Year Observational Cohort Study

    European journal of clinical investigation

  7. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (general population).

    “All TyG-derived indices were significantly associated with higher CVD risk”

    Humansgeneral population

    Predictive value of the triglyceride-glucose index combined with novel body shape indices for cardiovascular disease: a cross-sectional study based on NHANES

    European review for medical and pharmacological sciences

  8. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (adjusted HR = 4.597).

    “the TyG index remained strongly associated with incident CVD (adjusted HR = 4.597, p”

    Humans12-29 monthsn = 553

    Association Between the Triglyceride-Glucose Index and Incident Cardiovascular Disease in Non-diabetic Adults: A Prospective Cohort Study

    Cureus

  9. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans among participants who reverted to normoglycaemia (adjusted HRs 1.89-2.52).

    “Among participants who reverted to normoglycaemia, high cumulative TyG-derived indices were significantly associated with higher CVD risk (adjusted HRs 1.89-2.52; all p < 0.05).”

    Humansamong participants who reverted to normoglycaemiamedian 5.0-year follow-up

    Insulin Resistance-Adiposity Burden and Incident Cardiovascular Disease Across Glycaemic Transitions in Prediabetes: Risk Stratification After Reversion to Normoglycaemia

    Diabetes, obesity & metabolism

  10. Triglyceride-glucose index is linked with a higher risk of cardiovascular disease in humans (highest TyG quartile compared to lowest) (HR 2.073, 95% CI 1.233 to 3.488).

    “The highest TyG quartile was significantly associated with higher risks of CVD (HR = 2.073; 95% CI: 1.233 to 3.488)”

    Humanshighest TyG quartile compared to lowest

    Reassessing of the incremental predictive value of triglyceride-glucose index beyond traditional cardiovascular risk factors: a cohort study based on the China health and nutrition survey and meta-analysis

    Frontiers in cardiovascular medicine

All 12

More on Triglyceride-glucose index

Obesity

upin humans9upin reviews1

10 studies
  1. Obesity is associated with cardiovascular disease in humans (Community-dwelling adults in Amasya, Türkiye; adjusted for age and sex) (aOR 2.29, 95% CI 2.05–2.56).

    “cardiovascular disease (aOR = 2.29, 95% CI 2.05-2.56)”

    HumansCommunity-dwelling adults in Amasya, Türkiye; adjusted for age and sexBoth; 50.6% womensn = 22,667

    Population burden of diabetes, hypertension, and cardiovascular disease attributable to obesity: a community-based study in Türkiye

    Frontiers in public health

  2. Obesity is linked with a higher risk of cardiovascular disease in younger adults.

    “Over a median follow-up of 4.5 years, the metabolic factors exhibited strong associations with incident CVD in younger adults which gradually attenuated with advancing age.”

    Humansin younger adultsmedian follow-up of 4.5 years

    Cardiovascular risk from metabolic burden weakens with age

    The Lancet regional health. Western Pacific

  3. Obesity is linked with a higher risk of cardiovascular disease in premenopausal women without MASLD (aHR 1.10, 95% CI 1.04-1.17).

    “Among women without MASLD, general obesity was associated with risk before menopause (adjusted hazard ratio [aHR] 1.10, 95% confidence interval [CI] 1.04-1.17”

    Humansin premenopausal women without MASLDfemales

    Associations of General and Central Obesity with Cardiovascular Risk by Menopausal and MASLD Status

    Biomedicines

  4. Obesity is linked with a higher risk of cardiovascular disease in humans (BMI-based persistent obesity) (aHR 1.31, 95% CI 1.20-1.44).

    “persistent obesity was the only obesity-status trajectory associated with higher CVD risk (adjusted hazard ratio (aHR) 1.31, 95% confidence interval (CI) 1.20-1.44).”

    HumansBMI-based persistent obesity

    BMI-Based and Clinical-Obesity Trajectories and Incident Cardiovascular Disease: A Prospective UK Biobank Study

    Journal of clinical medicine

  5. Obesity is associated with cardiovascular disease in middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death) (aHR 1.49 [95% CI 1.11, 2.00]).

    “middle aged (aHR 1.49 [95% CI 1.11, 2.00]) and older (aHR 1.20 [95% CI 0.60, 2.41]).”

    Humansin middle-aged (31-60 years) PWH at ART initiation (composite outcome of CVD/cancer/death)

    Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

    EClinicalMedicine

  6. Obesity raises the risk of cardiovascular disease.

    “Accumulating evidence identifies obesity as a major independent risk factor for the development and progression of cardiovascular disease (CVD).”

    Review

    Evidence and mechanisms linking obesity to cardiovascular disease

    The journal of cardiovascular aging

  7. Obesity raises the risk of cardiovascular disease in humans.

    “being simultaneously an independent cardiovascular risk factor and being in the etiopathogenesis of other risk factors, namely diabetes.”

    Review

    Obesity and the heart: “Dangerous Liaisons”

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

  8. Obesity raises the risk of cardiovascular disease in humans.

    “Obesity prevalence has increased drastically over the last three decades, contributing to disability, lower life expectancy, and higher risk of CVD”

    Review

    Obesity, lipids, inflammation, and healthy aging

    Progress in cardiovascular diseases

  9. Obesity raises the risk of cardiovascular disease in humans.

    “excess prepregnancy weight, which has been associated with a higher risk of adverse maternal and fetal outcomes, including hypertension-related disorders, gestational diabetes, preeclampsia, and long-term cardiovascular complications”

    Review

    Weight Management Before Pregnancy to Reduce Cardiovascular Risk

    Cardiology in review

  10. Obesity raises the risk of cardiovascular disease in sarcopenic or frail subjects.

    “Obesity appears to play a crucial role in mediating the cardiovascular risk of both sarcopenic and frail patients.”

    Reviewin sarcopenic or frail subjects

    Interrelationship Between Sarcopenia, Frailty and Cardiovascular Disease-The Crucial Role of Obesity in Hypothesis Generation-A Narrative Review

    Journal of personalized medicine

More on Obesity

Hypertension

upin humans9OR 1.88–2.01

9 studies
  1. Cardiovascular disease is associated with hypertension in humans (Saudi adults attending primary healthcare clinics; multivariable adjustment) (OR 2.01, 95% CI 1.01–4.06).

    “history of cardiovascular disease (OR = 2.01, 95% CI: 1.01–4.06) remained associated with hypertension.”

    HumansSaudi adults attending primary healthcare clinics; multivariable adjustmentn = 525

    Factors Associated with Hypertension Among Saudi Adults Attending Primary Healthcare Clinics: A Cross-Sectional Study

    Healthcare (Basel, Switzerland)

  2. Hypertension is associated with cardiovascular disease in humans (Adults in Austria) (OR 1.88, 95% CI 1.54–2.30).

    “In Austria, hypertension (OR: 1.88, 95% CI: 1.54–2.30), and diabetes (OR: 1.81, 95% CI: 1.42–2.31) were also associated with CVDs”

    HumansAdults in Austrian = 9,501

    The association between cardiovascular diseases and their risk factors in Austria and Slovakia: regression analyses based on the European Health Interview Survey (2019)

    Expert review of pharmacoeconomics & outcomes research

  3. Hypertension is linked with a higher risk of cardiovascular disease in humans (youngest group) (HR 3.60).

    “In particular, the HR for hypertension declined from 3.60 in the youngest group to 2.12 in the middle-aged group, 1.41 in the older group, and 1.21 in the very old (≥80 years).”

    Humansyoungest group

    Cardiovascular risk from metabolic burden weakens with age

    The Lancet regional health. Western Pacific

  4. Hypertension is linked with a higher risk of cardiovascular disease in humans (low 10-year/high 30-year predicted risk group) (57.8% (95% CI, 45.1%-70.0%)).

    “Hypertension was the leading contributor to CVD events among participants with low 10-year/high 30-year predicted risk, accounting for 57.8% (95% CI, 45.1%-70.0%) of events in women”

    Humanslow 10-year/high 30-year predicted risk groupfemales

    Cardiovascular Disease Incidence and Risk Factor Contributions in Adults Aged 45 to 59 Years With Low 10-Year and High 30-Year Risk: Findings From REGARDS

    Circulation. Population health and outcomes

  5. Hypertension is linked with a higher risk of cardiovascular disease in humans (compared with normal BP) (HR 1.20, 95% CI 1.17-1.24).

    “Compared with normal BP, the HRs were 1.03 (95% CI 1.00-1.07) for elevated BP, 1.08 (1.05-1.11) for stage 1 hypertension, and 1.20 (1.17-1.24) for stage 2 hypertension.”

    Humanscompared with normal BP

    Blood pressure and cardiovascular risk in adults with non-proteinuric chronic kidney disease without diabetes

    Hypertension research : official journal of the Japanese Society of Hypertension

  6. Hypertension is linked with a higher risk of cardiovascular disease in humans (OR 1.88 (95% CI 1.708–2.076)).

    “hypertension (OR 1.88; 95%CI 1.708–2.076)”

    Humansfemales

    Sex-Specific Cardiovascular Risk Phenotypes Integrating Cardiometabolic, Psychosocial, and Autoimmune Determinants: A Population-Based Cross-sectional Study

    Research SquarePreprint

  7. Hypertension is linked with a higher risk of cardiovascular disease in humans (alone, compared with intact IC and no hypertension) (HR 1.68, 95% CI 1.46-1.93).

    “hypertension alone (HR 1.68, 95% CI 1.46-1.93) were associated with higher CVD risk”

    Humansalone, compared with intact IC and no hypertension

    Functional vulnerability beyond blood pressure: Intrinsic capacity impairment and cardiovascular risk stratification in three prospective aging cohorts

    Maturitas

  8. Hypertension is linked with a higher risk of cardiovascular disease in humans (alone) (HR 1.42, 95% CI 1.40-1.44).

    “adjusted HRs were 1.42 (95% CI: 1.40-1.44) for hypertension alone”

    Humansalonefemales

    Premature menopause and hypertension as combined risk factors for cardiovascular events in women: a nationwide cohort analysis

    Menopause (New York, N.Y.)

  9. Hypertension raises the risk of cardiovascular disease in humans.

    “Hypertension is a major risk factor for cardiovascular disease”

    Review

    Management of Hypertension in Older Adults

    Korean Journal of Geriatrics & Gerontology

More on Hypertension

Hypertensive disorders of pregnancy

upin humans8

8 studies
  1. Hypertensive disorders of pregnancy is linked with a higher risk of cardiovascular disease in humans.

    “HDP showed the strongest associations with both hypertension and CVD, attenuating with age.”

    Humansn = 737,257

    A multistate prediction model for hypertension and cardiovascular disease after pregnancy using routine care data in the Netherlands

    European journal of preventive cardiology

  2. Hypertensive disorders of pregnancy is linked with a higher risk of cardiovascular disease in humans (without prior CVD) (aHR 1.72, 95% CI 1.49-1.98).

    “A recorded history of HDP was associated with a 72% higher CVD risk (aHR=1.72, 95%CI 1.49-1.98).”

    Humanswithout prior CVD5 yearsfemales

    Recording of Hypertensive Disorders of Pregnancy and Subsequent Cardiovascular Risk Among New Zealand Women

    European heart journal. Quality of care & clinical outcomes

  3. Hypertensive disorders of pregnancy is associated with cardiovascular disease in humans.

    “hypertensive disorders of pregnancy may provide clinically relevant information about subsequent cardiovascular risk.”

    Reviewfemales

    Beyond traditional risk factors: Social, reproductive, and environmental determinants of cardiovascular health in women

    Current problems in cardiology

  4. Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.

    “Hypertensive disorders of pregnancy (HDP) affect approximately 1 in 7 pregnancies in the United States and are increasingly recognized as early and independent markers of lifetime cardiovascular disease.”

    Review

    Hypertensive Disorders of Pregnancy: An Updated Review of Short- and Long-Term Cardiovascular Implications

    Current Cardiovascular Risk Reports

  5. Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.

    “Women with pregnancies complicated by hypertensive disorders of pregnancy (HDP) are at significantly increased risk of cardiovascular (CVD) and metabolic diseases.”

    Reviewfemales

    Optimisation of maternal cardiometabolic outcomes after hypertensive disorders of pregnancy

    Women's health (London, England)

  6. Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.

    “HDP are directly linked to an increased risk of long-term cardiometabolic and kidney disease in mothers and offspring.”

    Reviewfemales

    Hypertensive disorders of pregnancy and the risk for hypertension and cardiovascular and kidney disease. International Society of Hypertension position paper, endorsed by the World Hypertension League and European Society of Hypertension

    Journal of hypertension

  7. Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans.

    “HDP is associated with significant maternal and perinatal morbidity, and can contribute to multiple cardiovascular diseases.”

    Reviewfemales

    Hypertensive disorders of pregnancy and women's health throughout the life course: an update review 2025-2026

    Hypertension research : official journal of the Japanese Society of Hypertension

  8. Hypertensive disorders of pregnancy raises the risk of cardiovascular disease in humans (later in life).

    “Hypertensive disorders of pregnancy identify women who are at higher risk of developing cardiovascular disease later in life”

    Reviewlater in lifefemales

    Mechanisms of Hypertension in Women: Interactions Between Vascular Ageing, Metabolic Dysfunction, and Hormonal Regulation

    Biomedicines

More on Hypertensive disorders of pregnancy

Clonal hematopoiesis of indeterminate potential

upin humans6upin reviews1

7 studies
  1. Clonal hematopoiesis of indeterminate potential is associated with cardiovascular disease.

    “CHIP is associated with cardiovascular disease, heart failure, and increased mortality.”

    Review

    Clonal Hematopoiesis and Biological Aging: An Emerging Biomarker for Longevity Medicine

    Cureus

  2. Clonal hematopoiesis of indeterminate potential raises the risk of cardiovascular disease in humans.

    “Clonal hematopoiesis is associated with elevated risks of cardiovascular disease and cancer.”

    Review

    Telomeres in Aging: Links to Clonal Hematopoiesis, Cardiovascular Disease, and Cancer

    The American journal of medicine

  3. Clonal hematopoiesis of indeterminate potential is associated with cardiovascular disease in humans.

    “has been linked to a variety of nonmalignant conditions, such as cardiovascular and inflammatory disease”

    Review

    Clinical management of clonal hematopoiesis

    Cancer

  4. Clonal hematopoiesis of indeterminate potential raises the risk of cardiovascular disease in humans.

    “Clonal hematopoiesis of indeterminate potential (CHIP) has emerged as an independent and potent cardiovascular risk factor.”

    Review

    Designing Cardiovascular Outcomes Trials in Clonal Hematopoiesis of Indeterminate Potential

    JAMA cardiology

  5. Clonal hematopoiesis of indeterminate potential raises the risk of cardiovascular disease in humans.

    “CH is associated with an increased risk of hematological malignancies and cardiovascular diseases”

    Review

    Clonal hematopoiesis in immune-related and neurological disorders

    Immunological medicine

  6. Clonal hematopoiesis of indeterminate potential raises the risk of cardiovascular disease in humans.

    “CHIP mutations, present in hematopoietic stem cells and their progeny, have been associated with increased risk of CVD”

    Review

    Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review

    Vascular medicine (London, England)

  7. Clonal hematopoiesis of indeterminate potential is associated with cardiovascular disease in humans.

    “Beyond hematologic malignancies, CH has also been linked to cardiovascular and inflammatory diseases”

    Review

    Clonal hematopoiesis and myeloid neoplasms: from molecular basis to clinical implications

    [Rinsho ketsueki] The Japanese journal of clinical hematology

More on Clonal hematopoiesis of indeterminate potential

Sarcopenic obesity

upin humans5HR 1.39

5 studies
  1. Sarcopenic obesity is associated with cardiovascular disease in humans (Older Chinese adults; fully adjusted Cox models) (HR 1.39, 95% CI 1.09–1.77).

    “SO was associated with a higher hazard of incident CVD (HR = 1.39, 95% CI 1.09–1.77; P = 0.008).”

    HumansOlder Chinese adults; fully adjusted Cox modelsn = 5,971

    Heterogeneous obesity phenotypes and late-life health in China

    BMC geriatrics

  2. Cardiovascular disease is associated with sarcopenic obesity in humans (Indian adults) (aOR 2.19; 95% CI: 1.17–4.09).

    “Diabetes mellitus (aOR 2.49; 95% CI: 1.45–4.28) and cardiovascular disease (aOR 2.19; 95% CI: 1.17–4.09) were the strongest comorbid predictors.”

    ReviewIndian adults

    The double burden paradox: sarcopenic obesity prevalence and predictors in the Indian adult population: a systematic review and meta-analysis

    BMC public health

  3. Sarcopenic obesity is associated with cardiovascular disease in humans.

    “cardiovascular disease (three studies), metabolic syndrome (one study)”

    Review

    Adverse outcomes of sarcopenic obesity in older adults: a scoping review

    Frontiers in nutrition

  4. Sarcopenic obesity raises the risk of cardiovascular disease in humans.

    “Sarcopenic obesity has been associated with an increased risk of cardiovascular diseases, type 2 diabetes, frailty, disability, and mortality.”

    Review

    WHY SARCOPENIC OBESITY IS THE STRATEGIC INTERSECTION? – A NARRATIVE REVIEW

    International Journal of Innovative Technologies in Social Science

  5. Sarcopenic obesity is associated with cardiovascular disease in humans.

    “strong association with metabolic disorders, cardiovascular diseases, frailty, disability, and increased mortality.”

    Review

    Sarcopenic Obesity in Older Adults: A Comprehensive Review of Epidemiology, Risk Factors, Complications, Prevention, and Management

    International Journal of Science and Research (IJSR)

More on Sarcopenic obesity

Smoking

upin humans4downin humans1HR 0.68

5 studies
  1. Smoking is associated with cardiovascular disease in humans (breast cancer survivors) (aHR 1.93, 95% CI 1.29–2.89).

    “Heavy smoking was associated with a high CVD risk in survivors of breast (aHR, 1.93; 95% CI, 1.29–2.89) and colorectal cancers (1.42; 1.26–1.60).”

    Humansbreast cancer survivorsheavy smoking

    Cardiovascular Risk Factors and Incident Cardiovascular Disease Among Cancer Survivors in Korea

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  2. Smoking is associated with cardiovascular disease in humans (Participants with COPD; smokers compared with never smokers).

    “women with COPD who smoke remain at higher risk for CVD than their never-smoking counterparts.”

    HumansParticipants with COPD; smokers compared with never smokersMedian follow-up of 10 yearsfemales

    Lung disease linked to cardiovascular disease in never-smokers

    Chinese medical journal

  3. Smoking is linked with a higher risk of cardiovascular disease in humans (AOR=9.86, 95% CI 1.13 to 86.14).

    “smoking (AOR=9.86, 95% CI 1.13 to 86.14)”

    Humans

    Cardiovascular disease risk and its behavioural correlates among university students in Punjab, India: a cross-sectional analytical study

    BMJ public health

  4. Smoking is associated with cardiovascular disease in humans (HR = 0.68, 95% CI = 0.49-0.97).

    “The associations between composite lifestyles and CVDs were mainly driven by body mass index (HR = 0.47, 95% CI = 0.34-0.65) and smoking (HR = 0.68, 95% CI = 0.49-0.97).”

    Humans2002-2021n = 11,218

    The Relationship Between Fetal Growth, Adult Lifestyle Patterns and the Risk of Cardiovascular Diseases

    Journal of prevention (2022)

  5. Smoking raises the risk of cardiovascular disease in humans.

    “This trend worsens CVDs like heart attacks, strokes, and hypertension.”

    Review

    Tobacco Smoking and Cardiovascular Health in Africa: Trends, Interventions, and Policy Implications-A Narrative Review

    Health science reports

More on Smoking

Metabolic dysfunction-associated steatotic liver disease

upin humans5HR 1.98

5 studies
  1. Metabolic dysfunction-associated steatotic liver disease is linked with a higher risk of cardiovascular disease in humans across menopausal stages.

    “MASLD was associated with higher CVD risk regardless of menopausal status”

    Humansacross menopausal stagesfemales

    Associations of General and Central Obesity with Cardiovascular Risk by Menopausal and MASLD Status

    Biomedicines

  2. Metabolic dysfunction-associated steatotic liver disease is linked with a higher risk of cardiovascular disease in individuals with chronic HBV infection (HR 1.98, 95% CI 1.49-2.63).

    “cardiovascular diseases ( HR= 1.98, 95% CI, 1.49-2.63)”

    Humansin individuals with chronic HBV infectionmedian follow-up: 13.7 years

    Concurrent MASLD and Long-term Outcomes in HBV-infected Individuals: A Population-based Cohort Study

    Biomedical and environmental sciences : BES

  3. Metabolic dysfunction-associated steatotic liver disease is associated with cardiovascular disease in humans (Standardized total association β=0.182 (95% CI, 0.154–0.210)).

    “The pooled standardized total association between MASLD and CVD was β=0.182 (95% CI, 0.154-0.210).”

    Review

    Metabolic and Hepatic Contributions to Cardiovascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analytic Structural Equation Modeling Study

    AHA Scientific Sessions 2026 abstract

  4. Metabolic dysfunction-associated steatotic liver disease raises the risk of cardiovascular disease in humans.

    “patients with MASLD have a clinical and substantial increase in risk of all forms of cardiovascular disease”

    Reviewin humans

    Cardiovascular disease risk in patients with and without metabolic dysfunction-associated steatotic liver disease: A clinical and subclinical evaluation

    American heart journal plus : cardiology research and practice

  5. Metabolic dysfunction-associated steatotic liver disease raises the risk of cardiovascular disease in humans.

    “is associated with higher risks of kidney function decline, cardiovascular events, and mortality.”

    Review

    Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiovascular, and Kidney Disease: Triple Challenges

    Clinical journal of the American Society of Nephrology : CJASN

More on Metabolic dysfunction-associated steatotic liver disease

Exercise

downin humans5OR 1.47

5 studies
  1. Exercise is linked with a lower risk of cardiovascular disease in humans (patients with hypertension) (OR = 1.47 for lack of exercise, 95% CI: 1.07-1.78, P = .001).

    “lack of regular exercise (OR = 1.47, 95% CI: 1.07-1.78, P = .001)”

    Humanspatients with hypertension90 daysn = 1,256

    Prediction of cardiovascular event risk within 90 days in patients with hypertension: A study based on random forest and nomogram models

    Medicine

  2. Exercise is linked with a lower risk of cardiovascular disease in humans (hypertension) (HR 0.80, 95% CI 0.71–0.89).

    “Significantly reduced CVD risks were observed in the morning (HR 0.83, 95% CI 0.73–0.95), afternoon (HR 0.80, 95% CI 0.71–0.89).”

    Humanshypertension

    Optimal timing of physical activity for patients with hypertension: A prospective cohort study from UK Biobank

    Research SquarePreprint

  3. Exercise is linked with a lower risk of cardiovascular disease in humans (transition from metabolic to cardiovascular-metabolic disease in CHARLS) (HR = 0.71, 95% CI 0.62–0.82).

    “were most pronounced for cardiovascular onset and for the transition from metabolic to cardiovascular-metabolic disease (CHARLS: HR = 0.71, 95% CI 0.62–0.82; SHARE: HR = 0.80, 95% CI 0.71–0.89).”

    Humanstransition from metabolic to cardiovascular-metabolic disease in CHARLSn = 19,533

    Intensity of Physical Activity and the Trajectory of Cardiovascular-Kidney-Metabolic Multimorbidity: A Multistate Analysis of Two Population-Based Cohorts

    Research SquarePreprint

  4. Exercise lowers the risk of cardiovascular disease in humans.

    “Evidence from randomized trials supports cardiovascular risk-factor and event reduction with selected dietary and exercise interventions”

    Review

    Modifiable Lifestyle Factors in Cardiovascular Disease Prevention: Current Evidence and Future Directions

    Nutrients

  5. Exercise lowers the risk of cardiovascular disease in humans (postmenopausal women).

    “Lifestyle interventions, such as structured exercise, show promise for reducing risk”

    Reviewpostmenopausal womenfemales

    The Silent Vascular Shift: Endothelial Dysfunction and Cardiovascular Risk in Menopausal Women

    Cardiovascular & hematological disorders drug targets

More on Exercise

Mortality

upin humans5

5 studies
  1. Cardiovascular disease predicts mortality in humans (re-occurring claim three years before index death in adults with Down syndrome).

    “The most influential predictors of mortality were any claim for dementia, any claim for pneumonia, re-occurring claim for cardiovascular disease three years before index death, and any claim for heart failure and epilepsy.”

    Humansre-occurring claim three years before index death in adults with Down syndrome11 yearsn = 137,293

    Dementia and pneumonia linked to deaths in Down syndrome

    medRxiv : the preprint server for health sciencesPreprint

  2. Cardiovascular disease is linked with a higher risk of mortality in CKD patients aged ≥75 (PAF: 12.6% [95% CI: 12.1%, 13.1%]).

    “CVD (12.6% [12.1%, 13.1%]) was the most influential factor in patients aged ≥75.”

    Humansin CKD patients aged ≥75

    Risk Factors for All-Cause and Cause-Specific Mortality in Patients with Chronic Kidney Disease: Age-Specific Associations and Attributable Burden

    Kidney diseases (Basel, Switzerland)

  3. Cardiovascular disease raises the risk of mortality in humans.

    “Cardiovascular diseases remain the leading cause of global mortality”

    Review

    From structural biomimicry to functional regeneration: Advances and translational challenges of 3D bioprinting in cardiovascular medicine

    International Journal of Bioprinting

  4. Cardiovascular disease raises the risk of mortality in humans.

    “Cardiovascular disease became the leading cause of death among Hispanic individuals in the United States in 2022.”

    Review

    State of Cardiovascular Disease and Stroke in Hispanic/Latino Adults in the United States: A Scientific Statement From the American Heart Association

    Circulation

  5. Cardiovascular disease is associated with mortality in 2021 in China (48.98% of rural deaths and 47.35% of urban deaths).

    “accounting for 48.98% of rural deaths and 47.35% of urban deaths in 2021, approximately 2 in every 5 deaths were attributable to CVD.”

    Reviewin 2021 in China

    Report on Cardiovascular Health and Diseases in China 2025: An Updated Summary

    Biomedical and environmental sciences : BES

Icosapent ethyl

downin humans1

1 study
  1. Icosapent ethyl lowers the risk of cardiovascular disease in humans (good adherers (took study drug for ≥1.5 years)) (29-30% risk reduction).

    “‘Good adherers’ were defined as participants who took IPE for ≥1.5 years (n=6921), and they experienced a risk reduction of 29-30%.”

    Human trialgood adherers (took study drug for ≥1.5 years)4g/dayn = 6,921

    Adherence and legacy effects of high dose eicosapentaenoic acid in hypertriglyceridemia and high CV risk – REDUCE-IT Legacy

    ESC Congress 2026 abstract

More on Icosapent ethyl

Atorvastatin

downin humans1HR 0.7

1 study
  1. Atorvastatin lowers the risk of cardiovascular disease in humans (without clinical cardiovascular disease) (HR 0.70, 95% CI 0.61–0.82, P<0.001).

    “a primary cardiovascular event had occurred in 297 participants (10.9 events per 1000 person-years) in the atorvastatin group and in 412 participants (15.5 events per 1000 person-years) in the placebo group”

    Human trialwithout clinical cardiovascular disease40 mg once daily5.9 yearsn = 9,971

    Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults

    The New England journal of medicine

More on Atorvastatin

All 548

Trial sponsors

Funding

573 grants since 2016

National Heart, Lung, and Blood Institute$322MNational Institute on Aging$27.5MJapan Society for the Promotion of Science¥279M

Latest

BMC Medicine

Liver risk scores linked to dementia, cancer and death

The highest versus lowest quarter of laboratory-based scores was linked to 5.57 times the dementia risk at any given time.The highest versus lowest quarter of laboratory-based scores was linked to 5.57 times the dementia risk at any given time.

Cohort · 88,449 peopleVascular dementia
JACC Advances

Four risk profiles linked to differing death risks in US adults

The high-blood-sugar and urine-protein group was linked to the highest risk of death over time, estimated at 2.59 times that of adults at stages 0 or 1.The high-blood-sugar and urine-protein group was linked to the highest risk of death over time, estimated at 2.59 times that of adults at stages 0 or 1.

Cohort · 8,761 peoplePopulations

See all 23,192 papers on cardiovascular disease